OPTALGIN DROPS

Country: Iżrael

Lingwa: Ingliż

Sors: Ministry of Health

Ingredjent attiv:

DIPYRONE

Disponibbli minn:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Kodiċi ATC:

N02BB02

Għamla farmaċewtika:

DROPS

Kompożizzjoni:

DIPYRONE 500 MG/ML

Rotta amministrattiva:

PER OS

Tip ta 'preskrizzjoni:

Not required

Manifatturat minn:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Grupp terapewtiku:

METAMIZOLE SODIUM

Żona terapewtika:

METAMIZOLE SODIUM

Indikazzjonijiet terapewtiċi:

Relief of moderate to severe pain as in headache, toothache, dysmenorrhea andfor high fever that does not respond to other measures.

Data ta 'l-awtorizzazzjoni:

2011-08-31

Fuljett ta 'informazzjoni

PATIENT PACKAGE INSERT
IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
The preparation shall be sold
without a doctor’s prescription
OPTALGIN
®
DROPS FOR ORAL ADMINISTRATION
COMPOSITION
Each 1 ml (25 drops) contains:
Dipyrone 500 mg
For the list of inactive ingredients in the
preparation see section 6 - “Further
Information”.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY
BEFORE USING THE MEDICINE. This leaflet
contains concise information about the
medicine. If you have further questions,
refer to the doctor or pharmacist.
THIS MEDICINE IS GIVEN WITHOUT NEED
FOR A DOCTOR'S PRESCRIPTION. YOU SHOULD
TAKE THE MEDICINE CORRECTLY. THE DROPS
ARE NOT INTENDED FOR INFANTS WEIGHING
LESS THAN 5 KG. CONSULT A PHARMACIST
IF YOU NEED FURTHER INFORMATION. YOU
SHOULD REFER TO THE DOCTOR IF THE
FEVER LASTS FOR MORE THAN 3 DAYS OR
PAIN PERSISTS FOR MORE THAN 7 DAYS,
DESPITE USE OF THE MEDICINE. THE RISK OF
AGRANULOCYTOSIS INCREASES IF TREATMENT
CONTINUES FOR MORE THAN 7 DAYS (SEE
“SIDE EFFECTS” SECTION).
1.
WHAT
IS
THE
MEDICINE
INTENDED FOR?
The medicine is intended for the relief
of moderate to strong pain, such as
headache, toothache and menstrual
pain, and for lowering high fever that
does not respond to other measures
of treatment.
THERAPEUTIC GROUP: Optalgin
®
Drops
contain an active ingredient belonging
to the pyrazoline group.
2.
BEFORE USING THE MEDICINE
DO NOT USE THE PREPARATION IF:
∙ Do not use the medicine when you
are pregnant or breastfeeding.
∙ Do not use this medicine if you
have
a
known
sensitivity
to
the active ingredient dipyrone
(metamizole), propyphenazone,
phenazone, phenylbutazone or to
any of the inactive ingredients of the
medicine.
∙ Do not use this medicine for mild
pains.
∙ Do not use this medicine if you
have a known deficiency of the
G6PD enzyme (“sensitivity to fava
beans”).
∙ Do not use if you suffer from a blood
system impairment.
∙ Do not use this medicine if you
suffer from acute hepatic porphyria
(an inherited disease in which
there is increased